Diabetic Peripheral Neuropathy
Diabetic peripheral neuropathy is nerve damage caused by chronically high blood sugar and diabetes. It leads to numbness, loss of sensation, and sometimes pain in your feet, legs, or hands. It is the most common complication of diabetes.
We are looking for participants ages 18 to 75 who have DPN in their legs/feet. This is a double blinded study, which means neither you nor the study doctor will know what medication group you will be placed into. You will be randomly assigned by chance to receive either study medication or placebo (inactive medication); you will have 50% chance of receiving study medication. The study is 1 year long. There are 11 office visits to our site. Pleas fill out the survey and we will contact you with more information.
The purpose of this study is to determine the safety and efficacy of bilateral intramuscular injections of VM202 versus placebo in the treatment of painful diabetic neuropathy.
- Age 18 to 75;
- Documented history of Type I or II diabetes;
- No significant changes anticipated in diabetes medication regimen;
- No new symptoms associated with diabetes within the last 3 months prior to study entry;
- Diagnosis of painful diabetic peripheral neuropathy in both lower extremities woth pain for at least 6 months;
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02427464